An update on the management of sporadic ...
Type de document :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
PMID :
URL permanente :
Titre :
An update on the management of sporadic desmoid-type fibromatosis: a european consensus initiative between sarcoma patients euronet (spaen) and european organization for research and treatment of cancer (eortc)/soft tissue and bone sarcoma group (stbsg)
Auteur(s) :
Kasper, Bernd [Auteur]
University of Heidelberg, Medical Faculty
Baumgarten, C. [Auteur]
Garcia, J. [Auteur]
Bonvalot, Sylvie [Auteur]
Institut Curie [Paris]
Haas, R. [Auteur]
Antoni van Leeuwenhoek Hospital
Haller, F. [Auteur]
Friedrich-Alexander Universität Erlangen-Nürnberg = University of Erlangen-Nuremberg [FAU]
Hohenberger, P. [Auteur]
University of Heidelberg, Medical Faculty
Penel, Nicolas [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Messiou, C. [Auteur]
Van Der Graaf, W. T. [Auteur]
The institute of cancer research [London]
Gronchi, A. [Auteur]
Molecular Targeting Unit, Department of Research [Fondazione IRCCS Istituto Nazionale dei Tumori, Milan]
University of Heidelberg, Medical Faculty
Baumgarten, C. [Auteur]
Garcia, J. [Auteur]
Bonvalot, Sylvie [Auteur]
Institut Curie [Paris]
Haas, R. [Auteur]
Antoni van Leeuwenhoek Hospital
Haller, F. [Auteur]
Friedrich-Alexander Universität Erlangen-Nürnberg = University of Erlangen-Nuremberg [FAU]
Hohenberger, P. [Auteur]
University of Heidelberg, Medical Faculty
Penel, Nicolas [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Messiou, C. [Auteur]
Van Der Graaf, W. T. [Auteur]
The institute of cancer research [London]
Gronchi, A. [Auteur]
Molecular Targeting Unit, Department of Research [Fondazione IRCCS Istituto Nazionale dei Tumori, Milan]
Titre de la revue :
Annals of oncology . official journal of the European Society for Medical Oncology
Nom court de la revue :
Ann. Oncol.
Numéro :
28
Pagination :
2399-2408
Date de publication :
2017-10-01
ISSN :
0923-7534
Mot(s)-clé(s) en anglais :
aggressive fibromatosis
EORTC/STBSG
patient advocacy groups
SPAEN
treatment algorithm
desmoid
Mesh:Humans
Mesh:Fibromatosis
Mesh:Aggressive/therapy*
Mesh:Fibromatosis
Mesh:Aggressive/genetics
Mesh:Fibromatosis
Mesh:Aggressive/diagnosis*
Mesh:Randomized Controlled Trials as Topic
EORTC/STBSG
patient advocacy groups
SPAEN
treatment algorithm
desmoid
Mesh:Humans
Mesh:Fibromatosis
Mesh:Aggressive/therapy*
Mesh:Fibromatosis
Mesh:Aggressive/genetics
Mesh:Fibromatosis
Mesh:Aggressive/diagnosis*
Mesh:Randomized Controlled Trials as Topic
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Currently, there is no established or evidence-based ...
Lire la suite >Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Currently, there is no established or evidence-based treatment approach available for this disease. Therefore, in 2015 the European Desmoid Working Group published a position paper giving recommendations on the treatment of this intriguing disease. Here, we present an update of this consensus approach based on professionals' AND patients' expertise following a round table meeting bringing together sarcoma experts from the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group with patients and patient advocates from Sarcoma PAtients EuroNet. In this paper, we focus on new findings regarding the prognostic value of mutational analysis in desmoid-type fibromatosis patients and new systemic treatment options.Lire moins >
Lire la suite >Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Currently, there is no established or evidence-based treatment approach available for this disease. Therefore, in 2015 the European Desmoid Working Group published a position paper giving recommendations on the treatment of this intriguing disease. Here, we present an update of this consensus approach based on professionals' AND patients' expertise following a round table meeting bringing together sarcoma experts from the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group with patients and patient advocates from Sarcoma PAtients EuroNet. In this paper, we focus on new findings regarding the prognostic value of mutational analysis in desmoid-type fibromatosis patients and new systemic treatment options.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Université de Lille
Université de Lille
Date de dépôt :
2019-12-09T18:16:56Z
2020-05-28T09:28:01Z
2020-05-28T09:28:01Z
Fichiers
- PIIS092375341934935X.pdf
- Version éditeur
- Accès libre
- Accéder au document